[(2'S,3S,3'R,4S,4'R,5R,10S,13S,14S,17S)-3-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,4',10,13,14-pentamethyl-2'-propanoylspiro[1,2,3,5,6,7,11,12,15,16-decahydrocyclopenta[a]phenanthrene-17,5'-oxolane]-3'-yl] acetate
Internal ID | ec8b0c8e-836f-4807-8491-f0757f7fd93b |
Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Triterpenoids |
IUPAC Name | [(2'S,3S,3'R,4S,4'R,5R,10S,13S,14S,17S)-3-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,4',10,13,14-pentamethyl-2'-propanoylspiro[1,2,3,5,6,7,11,12,15,16-decahydrocyclopenta[a]phenanthrene-17,5'-oxolane]-3'-yl] acetate |
SMILES (Canonical) | CCC(=O)C1C(C(C2(O1)CCC3(C2(CCC4=C3CCC5C4(CCC(C5(C)CO)OC6C(C(C(C(O6)COC7C(C(C(CO7)O)O)OC8C(C(C(C(O8)CO)O)OC9C(C(C(C(O9)CO)O)O)O)OC1C(C(CO1)(CO)O)O)O)O)O)C)C)C)C)OC(=O)C |
SMILES (Isomeric) | CCC(=O)[C@@H]1[C@@H]([C@H]([C@@]2(O1)CC[C@@]3([C@@]2(CCC4=C3CC[C@@H]5[C@@]4(CC[C@@H]([C@]5(C)CO)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO[C@H]7[C@@H]([C@H]([C@H](CO7)O)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O[C@H]9[C@@H]([C@H]([C@@H]([C@H](O9)CO)O)O)O)O[C@H]1[C@@H]([C@](CO1)(CO)O)O)O)O)O)C)C)C)C)OC(=O)C |
InChI | InChI=1S/C59H94O29/c1-8-28(65)44-43(80-25(3)64)24(2)59(88-44)16-15-56(6)27-9-10-33-54(4,26(27)11-14-57(56,59)7)13-12-34(55(33,5)21-62)84-49-41(73)40(72)37(69)32(83-49)20-78-51-46(35(67)29(66)19-77-51)86-52-47(87-53-48(75)58(76,22-63)23-79-53)45(38(70)31(18-61)82-52)85-50-42(74)39(71)36(68)30(17-60)81-50/h24,29-53,60-63,66-76H,8-23H2,1-7H3/t24-,29+,30-,31-,32-,33-,34+,35+,36-,37-,38-,39+,40+,41-,42-,43-,44-,45+,46-,47-,48+,49+,50+,51+,52+,53+,54-,55-,56+,57+,58-,59+/m1/s1 |
InChI Key | KDCUCXDBDLDEFI-PORPJMEXSA-N |
Popularity | 0 references in papers |
Molecular Formula | C59H94O29 |
Molecular Weight | 1267.40 g/mol |
Exact Mass | 1266.58807696 g/mol |
Topological Polar Surface Area (TPSA) | 448.00 Ų |
XlogP | -4.00 |
There are no found synonyms. |
![2D Structure of [(2'S,3S,3'R,4S,4'R,5R,10S,13S,14S,17S)-3-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,4',10,13,14-pentamethyl-2'-propanoylspiro[1,2,3,5,6,7,11,12,15,16-decahydrocyclopenta[a]phenanthrene-17,5'-oxolane]-3'-yl] acetate 2D Structure of [(2'S,3S,3'R,4S,4'R,5R,10S,13S,14S,17S)-3-[(2R,3R,4S,5S,6R)-6-[[(2S,3R,4S,5S)-3-[(2S,3R,4S,5R,6R)-3-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-5-hydroxy-6-(hydroxymethyl)-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-4-(hydroxymethyl)-4,4',10,13,14-pentamethyl-2'-propanoylspiro[1,2,3,5,6,7,11,12,15,16-decahydrocyclopenta[a]phenanthrene-17,5'-oxolane]-3'-yl] acetate](https://plantaedb.com/storage/docs/compounds/2023/11/627767b0-86f3-11ee-a49f-01914a6ac63e.jpg)
Target | Value | Probability (raw) | Probability (%) |
---|---|---|---|
No predicted properties yet! |
Proven Targets:
CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
---|---|---|---|---|---|
No proven targets yet! |
Predicted Targets (via Super-PRED):
CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
---|---|---|---|---|
CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.24% | 91.11% |
CHEMBL226 | P30542 | Adenosine A1 receptor | 97.94% | 95.93% |
CHEMBL233 | P35372 | Mu opioid receptor | 95.47% | 97.93% |
CHEMBL2581 | P07339 | Cathepsin D | 93.34% | 98.95% |
CHEMBL4016 | P42262 | Glutamate receptor ionotropic, AMPA 2 | 92.93% | 86.92% |
CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 92.64% | 91.24% |
CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 92.01% | 96.09% |
CHEMBL1994 | P08235 | Mineralocorticoid receptor | 91.87% | 100.00% |
CHEMBL3137262 | O60341 | LSD1/CoREST complex | 90.88% | 97.09% |
CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 89.95% | 97.25% |
CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 89.53% | 95.50% |
CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 89.49% | 94.45% |
CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 89.35% | 97.36% |
CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 89.07% | 97.47% |
CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 88.88% | 89.00% |
CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 88.53% | 98.75% |
CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 88.10% | 99.23% |
CHEMBL1293249 | Q13887 | Kruppel-like factor 5 | 87.87% | 86.33% |
CHEMBL5255 | O00206 | Toll-like receptor 4 | 86.69% | 92.50% |
CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 86.67% | 94.33% |
CHEMBL259 | P32245 | Melanocortin receptor 4 | 86.54% | 95.38% |
CHEMBL1871 | P10275 | Androgen Receptor | 85.26% | 96.43% |
CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 85.12% | 95.89% |
CHEMBL340 | P08684 | Cytochrome P450 3A4 | 84.25% | 91.19% |
CHEMBL4303 | P08238 | Heat shock protein HSP 90-beta | 84.22% | 96.77% |
CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 83.73% | 92.86% |
CHEMBL2007 | P16234 | Platelet-derived growth factor receptor alpha | 83.05% | 91.07% |
CHEMBL3108638 | O15164 | Transcription intermediary factor 1-alpha | 82.97% | 95.56% |
CHEMBL4051 | P13569 | Cystic fibrosis transmembrane conductance regulator | 82.68% | 95.71% |
CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 82.43% | 100.00% |
CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 82.11% | 96.90% |
CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 81.62% | 96.00% |
CHEMBL241 | Q14432 | Phosphodiesterase 3A | 81.52% | 92.94% |
CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 81.50% | 82.50% |
CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 81.10% | 96.61% |
CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 80.99% | 92.32% |
CHEMBL2635 | P51452 | Dual specificity protein phosphatase 3 | 80.00% | 94.00% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
Veltheimia capensis |
PubChem | 101941073 |
LOTUS | LTS0211557 |
wikiData | Q105139089 |